v3.26.1
Stockholders' Deficit (Detail) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 22, 2026
Mar. 23, 2025
Stockholders' Deficit [Line Items]    
Balance $ (3,901,142)  
Net Income (Loss) 139,811 $ 149,651
Balance $ (3,906,773)  
Common Stock [Member]    
Stockholders' Deficit [Line Items]    
Balance (in shares) 33,627,992 34,281,927
Balance $ 336 $ 343
Issuance and cancellation of stock awards, net (in shares) 89,881 54,516
Issuance and cancellation of stock awards, net $ 1 $ 0
Tax payments for restricted stock upon vesting, (in shares) (32,337) (18,630)
Purchases of common stock, shares (188,304) (115,280)
Purchases of common stock, value $ (2) $ (1)
Exercises of stock options, (in shares) 6,091 28,280
Exercises of stock options   $ 0
Balance (in shares) 33,503,323 34,230,813
Balance $ 335 $ 342
Additional Paid-in Capital [Member]    
Stockholders' Deficit [Line Items]    
Balance 1,910 1,272
Tax payments for restricted stock upon vesting (337) (8,158)
Purchases of common stock, value (12,093) (10,132)
Exercises of stock options 1,892 7,529
Non-cash equity-based compensation expense 8,789 10,381
Balance 161 892
Retained Deficit [Member]    
Stockholders' Deficit [Line Items]    
Balance (3,898,622) (3,956,474)
Net Income (Loss) 139,811 149,651
Dividends declared on common stock and equivalents (67,278) (59,800)
Tax payments for restricted stock upon vesting (12,558)  
Purchases of common stock, value (63,525) (40,210)
Balance (3,902,172) (3,906,833)
Accumulated Other Comprehensive Loss [Member]    
Stockholders' Deficit [Line Items]    
Balance (4,766) (7,432)
Currency translation adjustment (331) 343
Balance $ (5,097) $ (7,089)